Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Post by Torontonineon May 07, 2020 2:27pm
158 Views
Post# 30999199

No new news

No new news How is LBL any different than VXL or any of the other small cap bio stocks. I'll tell you how . They have the goods and are learning the expertise of how to get a trial going. This literally fell in to their laps. VXL RVV and many other companies are still trying to develope a vaccine. LBL is the complete opposite they have the treatment ,but having a hard time manoeuvring it and getting to market The end game here is either pay big $ to get the trial going or partner up. They would burn the $ 6 Mil b4 going bankrupt and from my conversations with Guy they don't need to use that money. It's a line of credit. Dump if you want, hold if you want , but if this baby pops it will go fast.
<< Previous
Bullboard Posts
Next >>